|
⚲
|
| Promentis Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001470994 |
| Sale | 2009-08-14 ($2.5 M Offered, $1.7 M Sold) |
| Fund | |
| Phone | 2623029039 |
| Address | 826 N Plankinton Ave, Ste 300 Milwaukee, 53203 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-08-31 (D/A) |
| Exemption | 506, 4(6) |
| Remaining | $813,000 |
| Duration | One year or less |
| Revenue | No Revenues |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| David Baker PhD | Director | |
| Ed Barthell | Director | |
| Daniel Lawton | Executive Officer | |
| Patrick Schwarzschuette | Director | |
| Klaus Veitinger | Director |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Wang Xin
✚
|
0.0 | |
|
Wang Zhuo
✚
|
0.0 | |
|
Ward Douglas Edward
✚
|
0.0 | |
|
Ward Lynne
✚
|
0.0 | |
|
Wariner Sarah N
✚
|
0.0 | |
|
Warner Bryan
✚
|
0.0 | |
|
Warranty Hive Jan 2025 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Wand TopCo Inc
✚
|
0.0 | |
|
Warburg Pincus & Co US LLC
✚
|
0.0 | |
|
Wander John C
✚
|
0.0 |